TUBERCULOUS MENINGITIS
Clinical trials for TUBERCULOUS MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOUS MENINGITIS trials appear
Sign up with your email to follow new studies for TUBERCULOUS MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an arthritis drug save lives in HIV-TB meningitis?
Disease control Recruiting nowThis study tests whether adding adalimumab (a drug used for arthritis) to standard treatment can reduce deaths in HIV patients with tuberculosis meningitis. About 130 adults in Brazil, Mozambique, and Zambia will receive either adalimumab or placebo alongside anti-TB drugs and st…
Matched conditions: TUBERCULOUS MENINGITIS
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
Could a 6-Month drug cocktail beat 9 months for brain TB?
Disease control Recruiting nowThis study compares a 6-month treatment using high doses of four antibiotics against the standard 9-month regimen for tuberculous meningitis, a serious brain infection. About 330 adults and teens without HIV will take part. The goal is to see if the shorter treatment is just as s…
Matched conditions: TUBERCULOUS MENINGITIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 12, 2026 13:40 UTC